Five-day breast cancer treatment now available

October 22, 2010 By Dorsey Griffith

UC Davis Cancer Center now offers a new generation of radiation therapy that transforms a woman's breast cancer radiation treatment experience.

The method is the newest and most sophisticated form of "accelerated partial-breast irradiation," in which a conformal catheter is implanted temporarily into the cavity where the tumor has been surgically removed. The treatment, which takes just five days, is applied directly to the tumor site and minimizes radiation exposure to the heart, lung, ribs and skin. Accelerated partial-breast irradiation also focuses radiation on the area where 90 percent of breast tumors recur, close to the tumor bed.

"This program has several advantages over earlier programs that used older-generation radiation catheters," said Jyoti Mayadev, assistant professor of at UC Davis Cancer Center. "The main advantage is that we can sculpt the away from critical, normal structures and target the area at higher risk of recurrence, which is where the tumor started."

UC Davis Cancer Center is the only cancer treatment facility in the Sacramento metropolitan area that offers the new treatment method. Use of the technique represents a multi-disciplinary team approach involving cancer specialists in both surgery and radiation therapy.

Steven Chen, a UC Davis surgical oncologist, said the procedure is generally appropriate for women over 50 with early-stage breast tumors that have not spread to lymph nodes. Chen estimated that more than half of women diagnosed with would be eligible for this type of radiation therapy.

The radiation therapy delivery occurs within weeks of a patient's , a surgery in which the tumor is removed but the breast is conserved.

First, physicians use a CT scan to map the lumpectomy cavity and determine where to place the treatment applicator, said Mayadev. Once mapping is complete, a surgeon makes a small incision in the breast and places the thin applicator into the tumor bed. Within a day or two, the patient returns to the radiation oncology clinic for treatment planning.

The device itself contains a bundle of very thin catheters that attach on one end and can be expanded to conform to the shape of the cavity. The radiation is delivered through each catheter using a remote after-loading system, which is then disconnected until the next treatment. Unlike normal breast radiation therapy, which exposes the entire breast to radiation five times a week for up to six weeks, the new approach takes just two visits per day for five days.

Dolly Keehne of Penn Valley said she is not normally a good patient and almost couldn't get through her breast biopsy. So she dreaded radiation therapy after her tumor removal surgery. "I'm scared, and I shake," she said. "But this was so much easier than I anticipated. It was pain-free. From the first day to the last, it was unbelievable."

After her breast cancer diagnosis in July 2010, Keehne had searched for a program that offered the partial-breast irradiation approach. She had already endured kidney cancer treatment and wanted limited this time around.

"In the past five years, I have had at least 40 CT scans," she said. "I was afraid of having six weeks of radiation treatment. I jumped on the bandwagon because they could direct the radiation dose."

The treatment was painless and did not cause fatigue. "Treatment ended on Sept. 17, and I went to my nephew's wedding in Pismo Beach the next night. I felt fine."

Margaret McCoy of Rio Linda completed her treatment in mid-October. She said the entire experience was far easier than she had expected. "It was kind of scary to think about when they said they were going to put a device in my breast," she said. "But it was a piece of cake."

After her final treatment, McCoy said she and her daughter celebrated at a restaurant with dinner and a margarita.

Mayadev said the new approach improves on the older generation of partial-breast techniques because it requires just one incision instead of the insertion of many needles, while still keeping the flexibility of having many catheters to use to distribute the dose. The procedure is more comfortable for the patient without compromising on the distribution of the radiation dose.

Research has found that results with partial-breast irradiation are similar to results with whole-breast radiation therapy, which decreases the chance of tumor recurrence by more than 60 percent.

Mayadev said the new approach enhances the cancer center's wide-ranging armamentarium against breast cancer. "We can increase the local control while significantly lowering radiation doses to critical areas," she said, "potentially decreasing the risk of long-term radiation effects such as cardiac morbidity and radiation lung scarring."

Related Stories

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.